
Learn the key requirements for China food labeling compliance: mandatory label content, ingredient declarations, imported food requirements, and more.

Learn the latest China NMPA registration fees for imported and domestic drugs and medical devices.
%20Market%20A%20Guide%20for%20Foreign%20Manufacturers%20(1).avif)
Understand the pathway for intraocular lens (IOL) registration in China, including NMPA requirements and key compliance steps.

A complete guide to China hyaluronic acid registration, covering classification, NMPA requirements, and compliance steps for manufacturers.

Practical China medical device glossary explaining NMPA terms, with clear comparisons to US FDA and EU MDR terminology.
.avif)
Learn 5 key steps for China dental medical device registration, covering classification, biocompatibility testing, and legal agent selection.

Learn how a smart clinical trial strategy for medical devices in China can speed up NMPA approval and bring your product to market faster.

Get answers to common China medical device and IVD registration questions, from NMPA classification rules to testing and renewal requirements.

Learn how China medical device risk classification works under NMPA rules and see common compliance pitfalls to avoid.

Learn how China IVD risk classification works under NMPA rules and see common compliance pitfalls to avoid.

Gain clarity on often-misunderstood China Manufacture License (CML) requirements, including SELO approval, demo products, and CSEI audits.

Discover how leveraging Real World Data generated in the Greater Bay Area can accelerate market entry for medical products in China.

Learn about China's Unique Device Identification (UDI) system and how to navigate China’s evolving medical device market.

Identify China medical device GMP gaps and prepare QMS, supplier, data, and inspection controls before NMPA market entry.

China’s 15th Five-Year Plan signals stronger support for innovative drugs, advanced medical devices, reimbursement reform, and NMPA regulatory pathways.
.avif)
Learn about Cisema’s redesigned website with faster performance, clearer navigation and expanded Asia Pacific coverage.
Track all imported Class II and III medical device approvals in China with this monthly updated NMPA submission tracker.

Manufacturers seeking MRI registration in China must meet expanded technical, software, and validation requirements.

The new documents clarify expectations for Tier III variants, companion diagnostic clinical evaluation, tissue and plasma registration, and HLA-B*58:01 analytical validation.

New NCI rules reduce administrative burden, streamline dossiers, and expand opportunities to reuse existing safety data.

China's new BCI medical device guidance establishes classification and naming principles, giving manufacturers a clearer pathway to NMPA registration.

Review China's new draft standards for cosmetic cheilitis and contact urticaria before the August 15, 2026, consultation deadline.

New NMPA packaging size guidance encourages drug applicants to align pack sizes with clinical use, patient needs, and sustainability goals.

The latest Guidelines raise the compliance bar for online prescription drug sales, with stricter oversight for pharmacies and platforms.

Draft standards would introduce a unified 37-digit barcode system and update technical requirements for veterinary equipment supplied to China.

New Hainan MPA guidance clarifies how Lecheng real-world evidence can support imported product registration, labeling updates, and post-approval activities

New Trial CCC rules strengthen factory oversight, product consistency, and quality management requirements for manufacturers.

Learn how China's GB 7718-2025 food labeling standard and new digital label rules affect imported foods before the March 2027 compliance deadline.

New rules strengthen data governance and raise sponsor oversight duties from September 2026.

New ethics guidelines clarify consent, privacy, security, and governance expectations for human genetic data research in China.

China Customs has revised the 2026 sampling inspection program, adding and removing product categories that may face border inspections.

China approves new food ingredients, additives, and food-contact materials, creating new formulation and compliance considerations

New data on cosmetic registrations, ingredient filings, safety assessments, and standards development reveals key compliance trends in China.

New CCC requirements add GB 47372-2026 as a mandatory certification standard and require certificate conversion for affected products

The 2025 Drug Evaluation Report provides insights into key application trends, review activities, and developments across China's pharmaceutical sector.

The reformed framework overhauls policy to strengthen innovation while tightening evidence, supply, and compliance requirements.

The framework establishes filing rules, protection scope, and transitional requirements affecting innovative and overseas-originator drug applications in China.

The updated technical guideline expands regulatory expectations for manufacturing, impurity control, advanced analytics, stability studies, and biosimilar comparability.

China’s NMPA and six government agencies issued new measures that strengthen compliance requirements, anti-bribery controls, and oversight of pharmaceutical promotion activities.

The new framework introduces a distinct regulatory pathway for emerging therapies, with major implications for clinical development and market strategy.

China’s SAMR has released draft advertising review measures that would increase oversight of livestreaming and digital marketing while streamlining certain compliance requirements for regulated products.

The three revised CCC certification standards for low-voltage electrical equipment introduce new testing and compliance requirements.

New guidance highlights the need for earlier China development planning whenrelying on global trials, foreign clinical data, or multinational development strategies

New customs measures taking effect in December 2026 will reshape how cosmetics are inspected, cleared, labeled, and electronically verified in China.

7 product categories will be subject to revised energy efficiency labeling requirements under a phased rollout beginning in June 2026.

New measures define vigilance management, inspections, PSURs, trend reporting, and reporting requirements in 17 pilot regions

The new GMP for medical devices, effective Nov 1 2026, introduces stricter quality, personnel, and supplier controls.

China’s NMPA released a AI roadmap for smarter supervision across drugs, medical devices, and cosmetics regulation, covering AI-supported review, inspections, traceability, risk monitoring, and digital governance through 2035.

China’s NMPA updated the Medical Device Classification Catalogue, revising requirements and classifications for 31 product categories.

Malaysia and China launch a regulatory reliance pilot to streamline IVD medical device registration and accelerate cross-border market access.
.avif)
China’s NIFDC releases 6 new technical guidelines for high-risk cosmetics, impacting hair dye, perming, and sunscreen product compliance.

The reforms introduce new drug pricing rules, clarified conditional approval procedures, and tiered care measures.

CMDE maps 275 guideline updates, tightening requirements and giving manufacturers early visibility for planning and compliance.

CNCA issued 11 trial CCC certification implementation rules for fuses, electric tools, welding machines, automotive components, and safety glass.

China’s MIIT and nine ministries introduce a new AI ethics review and services framework establishing tiered oversight, compliance obligations, and governance pathways for AI activities in China.

China issues new guidelines on medical device adverse event risk evaluation and periodic report review, tightening post-market surveillance requirements

China’s CMDE releases a new IVUS registration review guideline, defining technical, clinical, and testing requirements for NMPA medical device registration

The NMPA announced a total of 28 updates on the classification catalogue for medical devices including 15 classification changes and 13 content updates.

China’s NMPA updates cosmetics testing methods, adding CBD detection and tighter impurity controls impacting global compliance.

SAMR introduce stricter recall and compliance requirements for enterprises involved in cross-border e-commerce retail imported food.

China’s NMPA releases 2025 annual report on medical device standardization, highlighting growth, innovation, and international alignment.

China’s NMPA is incorporating 18 revised cosmetics standards into the Safety and Technical Standards for Cosmetics.

China’s NMPA formally includes black ginseng extract, hydrolyzed sodium hyaluronate zinc, and galactomannan in the IECIC.

China’s National Medical Products Administration has issued its 2026 medical device standards plan, introducing 80+ new and revised standards

The draft 2026 catalogue defines which Class III medical devices would require clinical trial approval before trial initiation.

China NMPA’s 2025 report highlights growth in medical device approvals, including advanced imported devices.

China releases guiding principles for benefit-risk assessment using multi-regional clinical trial data to support global drug development.

China’s NMPA issues new guidance on clinical trial protocol pre-review for innovative devices, impacting overseas fast-track approvals.

China NMPA adds four new cosmetic testing methods effective July 2026, impacting compliance and safety assessment strategies.

China’s NMPA has opened consultation on a draft mandatory toothpaste safety standard that could tighten product requirements.

China releases new subject selection guidance for anti-tumor drug bioequivalence and pharmacokinetic studies.

China’s CCC mark pilot reform requires traceability QR codes for power banks, electric bicycles, and gas appliances.

China's HAF003 reform and participation in the "Tripling Nuclear Energy Declaration" signals stricter compliance and new opportunities.

China’s NMPA mandates full UDI coverage for all medical devices by 2029, linking compliance to registration, reimbursement, and market access.

China clarifies GACC Order 280 rules for imported food registration and customs declarations ahead of June 2026 enforcement.

The 26 new medical device standards cover orthopedic implants, IVDs, active devices, and software risk management.

Hong Kong’s Department of Health introduces Pre-NDA meetings to streamline new drug registrations under the “1+” mechanism.

The Department of Health has mandated MDACS listing for public procurement eligibility — see which devices are affected and how to prepare.

China’s CMDE announced revisions to the registration review guideline for aesthetic sodium hyaluronate injectable fillers.

China’s CDE released three 2026 trial guidelines on Phase III design for chronic insomnia, neuropathic pain, and depressive disorders.

NMPA CDE clarifies CMC expectations for preventive mRNA vaccines, focusing on LNP control, impurity management, and lifecycle comparability.

China’s CDE issued trial guidance on CMC lifecycle changes for cell therapies, emphasizing comparability and risk-based quality assessment.

China’s NMPA will apply ICH M14 to non-interventional real-world evidence safety studies initiated on or after its January 2026 announcement.

The draft 2026 catalogue defines which Class III medical devices would require clinical trial approval before trial initiation.

China’s State Council has revised the Drug Administration Law implementation regulations under Decree No.828, introducing innovation incentives, expanded data protection, and stricter MAH obligations effective May 15, 2026.

The NMPA has introduced faster review decisions, coordinated inspections, and improved temporary import pathways for urgently needed overseas-marketed drugs.

China medical device registrations 2023 annual report has been issued by the NMPA.

The Chinese authority CNCA issued an announcement regarding the China Compulsory Certification Implementation Rules, which accredited five more certification organizations. The much criticized CQC-monopoly especially regarding electric devices now belongs to the past. The new organizations will primarily deal with the following product-groups:CTC (Guangdong Quality Testing CTC Certification Co. LTD): Cables, switches, electric lighting, low-voltage electrical componentsCQM (China Certification Center for Quality Mark): switches, electric hand tools, welding machines, other electric componentsCESI (China Electronic Standardization Institute): Audio/video equipmentCVC (Guangzhou VKAN Certification and Testing Co. Ltd.): Circuit breaker, assembly locking, connections for electric installations (and accessories), electric motors and household appliancesCGC (China General Certification Center): Household appliances.For further information please contact:Cisema China Certification GmbHTel.: +49 89 4161 7389 – 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

AQSIQ is planning to introduce an official certificate of clearance for all food imports.On 1.10.2017 announcement 83 2017 issued by AQSIQ (Administration for Quality, Safety, Inspection and Quarantine of China) will come into force. From then on, all food exported to China must be accompanied by an official certificate of clearance, which is to be issued by the competent authorities in the country of origin. Up to now, AQSIQ has not communicated any details, like which authorities are accepted by AQSIQ or which information is to be contained in the certificate.Many of China's trade partners have already filed a note of protest at WTO against this regulation and the feasibility of the Chinese plans is most uncertain according to expert opinions.We shall inform you immediately, if there are any news on the certificate of clearance.For further information please contact:Cisema GmbHTel.: +49 89 4161 7389 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

Starting August 1st 2018 motorcycle helmets, electric blankets, heating pads and similar flexible heaters required the CCC certification of the P.R. China.

On 17.11.2017 the NMPA (China Food and Drug Administration) published a notice announcing that fee-charging tests (also referred to as sponsored tests) are accepted as part of the NMPA registration of medical devices (No. 2017-187).

On August 21st 2014 the CNCA has publicized its announcement 31/2904 dealing with the revised implementation rules for CCC-certification of all automotive products, vehicles and their components.The most significant adjustments affect the product group “interior materials”: New products have been included in this group such as sound and thermal insulation materials used in the engine compartment. Also certain products that before were free of CCC will need certification under the new rule. This applies for instance to instrument panels, center consoles, floor mats and boot linings for sports cars and convertibles.Also there are new definitions regarding inspection and spare part management, some of which have already been in use by the Chinese certification organizations over the past years.All new regulations will be officially implemented on January 1, 2015.For more detailed information please contact us:Cisema China Certification GmbHTel.: +49 89 4161 7389-00Fax: +49 89 7484 9956info@cisema.dewww.cisema.de

On 05.02.2018, the NIFDC (National Institutes for Food and Drug Control) – a unit under the NMPA (China Food and Drug Administration) – published a draft on two alternatives to animal testing: One for skin and one for eye irritation. The draft was open for public comment until 15.02.2018 and clearly indicates a major step towards the improvement of China’s technical cosmetics regulations and the replacement of animal testing in the future.

The NMPA published a new classification catalogue on August 31, 2017, with reference to more than 2,000 medical device examples.

Introducing QR code for the China Energy Label (CEL).Back in spring the Chinese authorities AQSIQ (General Administration of Quality Supervision, Inspection and Quarantine of P.R. China) and NDRC (National Development and Reform Commission) drafted a change of the energy efficiency labeling. The intention is to make it easier for Chinese consumers to check on the energy efficiency of a product using online media.See below example:[caption id="attachment_1345" align="alignnone" width="182"] credit: 24.08.2016: https://www.cnca.gov.cn/xxgk/ggxx/2016/201608/W020160803588217825962.pdf[/caption]With immediate effect the labels have to be adjusted and get approval from the China Energy Label Center (CELC). Starting October 1st 2016 the import of products to China carrying the old efficiency label will be problematic.What has also changed is that web shops have to include the QR-code in their product description. Distributors have to do incoming goods inspections, to check on the CELC-registration and ensure that only conformal goods are traded.For more information please contact:Cisema China Certification GmbHTel.: +49 89 4161 7389 - 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

In their announcement 23/2014 from July 2014, the Chinese certification authority CNCA has publicized the release and implementation of seventeen new “implementation rules” required for CCC certification.The new implementation rules apply to electric devices, such as cables and lines, switches and switching devices, low voltage motors, welding tools, domestic appliances, audio, video and IT-equipment, as well as non-electrical products such as safety glass, agricultural tools, theft alarm systems and decoration products.The new regulations will be officially implemented on September 1, 2014. Existing certificates are still valid, but the appropriate adjustments to the new rules should be done at the next available opportunity.For more detailed information please contact us:Cisema China Certification GmbHTel.: +49 89 4161 7389-00Fax: +49 89 7484 9956info@cisema.dewww.cisema.de

China RoHS 2.0 „Compliance Management Catalog“ progressing to next phase.On February 3rd 2016 the responsible authorities (published an update on the regulation for hazardous substances - RoHS 2.0. The regulation is effective since July 1st 2016 (we reported).Originally a „Compliance Management Catalog“ was scheduled for publishing in October 2016. The content should provide a definition, whether a mandatory registration, and possibly an inspection of the manufacturer, will be introduced. So far there was no progress. On July 28th 2017 a consultation of the authority MIIT with business representatives ended. We expect to receive further information about the future approaches for China RoHS by end of this year.For further information please contact:Cisema China Certification GmbHTel.: +49 89 4161 7389 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.de

According to the NMPA Announcement on 1.9.2017, the processing time for application for renewal of the registration will be increased.

Recalls of Medical Device Regulation Updated .On September 2nd 2016 a new draft for handling recalls of medical devices has been released. The revision will replace the current regulation 82/2010 from the Chinese Ministry of Health dated 28.06.2010. It describes the key points leading to a recall.
The draft also gives some guidelines for the management of recalls.
When there is proof of the defectiveness of the device, and the NMPA-Legal-Agent fails to report to the NMPA, the NMPA may initiate the recall.Violation of the regulations can result in fines for the NMPA Legal Agent or even cost him his license.Recalls will be published in the NMPA database stating details of the product, its manufacturer and NMPA Legal Agent.For more information please contact us:Cisema GmbHTel.: +49 89 4161 7389 – 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

NMPA – New Application Deadlines for Cosmetics. As of Sept.1st, 2017 the deadlines for the application of certificate renewals or changes will be as follows:
Further information on the above topic can be obtained from:Cisema GmbHTel.: +49 89 4161 7389 – 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

Die chinesische NMPA aktualisiert ihre Sicherheitsstandards für Inhaltsstoffe von Kosmetika ab dem 01.12.2016.

During the meeting of the Chinese State Council on 20.09.2017, it was decided to extend the CBEC Policy Grace Period for a second time. The regulation allows the introduction of unregistered cosmetics, medical devices, infant formulas and health foods into Chinese cross-border cities until 31.12.2018.

Cisema gave a talk on medical device registration as part of the webinar on hosted by the U.S. Commercial Service on December 13, 2017.

The BJCIQ published a procedure where CCC-liable goods may be imported in small quantities without CCC certification.

On 15.3.2018 the certification authority CNCA (Certification and Accreditation Administration of the P.R. China) announced on short term (announcement 10/2018) that the issuance of Permissions of Printing (PoP) for marking products with the CCC-logo (China Compulsory Certification) will be stopped as of 20.03.2018. According to the announcement, the owners of CCC certificates can start the marking immediately after receipt of the CCC certificate, provided they adhere to the guidelines. This procedure is similar to other well-known certification marks like E, CE or UL.

In 2015, the NMPA approved a total of 7,530 registrations for Class II and III products comparingly less than 2013 (7,875) and 2014 (8,834).

New product catalog and new HS* codes for the CCC certification in PR ChinaIn two recent successive announcements by CNCA ** with the numbers 30 and 36 the scope of the CCC (China Compulsory Certification) certification is re-regulated. The new catalog of the top certification authority of CHina covers 22 product groups and 157 categories with current descriptions and definitions. In order to unify the implementation by the local customs offices better, additionally the list of affected HS codes (tariff codes) was brought up to date. Both lists are available in their original version only in Chinese.For more information about CCC certification in the VR China please get in touch with us.* = Harmonized System** = Certification and Accreditation Administration of China

The CNCA (Certification and Accreditation Administration of the People's Republic of China) announced with its Notice No. 43-2017 that the CAQC (Cyberspace Administration of China) is allowed to process CCC (China Compulsory Certification) certification for product groups in the automotive sector.

The Chinese certification authority CNCA (Certification and Accreditation Administration) has updated the list of product categories subject to CCC certification (China Compulsory Certification). Quite a few products have for instance been added to category 11 the “Motor vehicles and safety-relevant accessories”. It now includes insulation material in the engine compartment, floor mats, dashboards and devices for indirect vision. Category 20 “children products” now also contains child-seats.The previous 22 categories were reduced by two: Latex products and medical devices have been switched to NMPA (China Food and Drug Administration).Currently the CCC certification requirements apply to the following product groups:
If you have any more questions please contact us at:Cisema China Certification GmbHTel.: +49 89 4161 7389 - 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

As of January 1, 2017, low volume imports will not be handled by the local CIQ any longer, but by the certification authorities.

CCC certification - dimensions of interior and insulation materials in the automotive sector further specified:On 01.01.2015 the new implementation guideline of the CNCA (Certification and Accreditation Administration of the People's Republic of China) for automotive interiors and insulating materials came into force (CNCA-C11-09:2014). With this regulation, a number of new components have been included in the scope of CCC certification (China Compulsory Certification). This led to an increase in the number of applications for CCC certification of products whose relevance was not clear.The competent Commission was therefore obliged to publish a further clarification of the Directive in December 2015. Based on last year's experience, especially with frame parts, components that completely cover a rectangle with the standard dimensions 356 x 100 mm are considered for certification. The final decision on compulsory certification clearly focuses on the geometry of the component. For example, a large component with several holes, one of which occupies more than 50% of the total area, may not be eligible for certification if the test sample cannot be cut in the required shape and size. In cases of doubt, the respective Chinese certification organisation makes an individual decision. Until now, smaller components were also accepted for certification if they reached the standard dimensions only in terms of length and width (e.g. in the form of a triangle). For affected components, certification can be maintained or cancelled if desired.Further information on the topics mentioned can be obtained from:Cisema China Certification GmbHTel.: +49 89 4161 7389-00Fax: +49 89 7484 9956info@cisema.dewww.cisema.de

NMPA Issues Charging Standards for Drug and Medical Device RegistrationOn May 27, the China Food and Drug Administration ("NMPA") released its “Charging Standards for Registration of Drugs and Medical Devices” which come into force immediately. For pharmaceuticals, foreign companies will have to pay for clinical trials or marketing approvals, medical device companies have to pay for class II and III registration. This applies to new and change applications as well as the extension after five years.For small to micro enterprises in China doing medical innovation, the NMPA has set up a preferential policy of waiving registration fees and supplementary application fees.For more information please contact us at:Cisema China Certification GmbHTel.: +49 89 4161 7389 - 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

Online Trade - Deliveries Classified as Products for Personal Use.As of 1st January 2018 the Chinese customs authorities will treat all commodities traded through CBEC as articles for personal use. The reason is that commodities traded through CBEC are for private persons and usually have a low value and low quantities.Another five pilot cities for CBEC will be nominated: Besides Hangzhou, Tianjin, Shanghai, Chongqing, Zhengzhou, Guangzhou, Ningbo,Shenzhen, Fuzhou und Pingtan, there will now be added Chengdu, Dalian, Qingdao, Suzhou und Hefei.More details for the supervision will be published shortly. It can be assumed, however, that certain product groups which normally need registration or certification, can be traded and imported freely through CBEC. Among these commodities are:Ordinary cosmetics such as lotion, cream, facial mask, shampoo
It has not been decided yet if the new regulation also applies to infant formula.Further information on this topic can be obtained from:Cisema GmbHTel.: +49 89 4161 7389 – 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

China Adjusts Its Import Control for Child Safety Seats and Alloy Wheels.With announcement 147/2014 the “General Administration of Quality Supervision, Inspection & Quarantine of China” (AQSIQ) and the “General Administration of Customs of China” (GACC) the entry/exit inspection-quarantine requirements have been imposed on car seats for children as well as automotive alloy wheels/parts.As of September 1st 2015 child safety seats are also subject to the mandatory CCC-certification.For more information please contact us:Cisema China Certification GmbHTel.: +49 89 4161 7389 – 00Fax: +49 89 7484 9956info@cisema.de www.cisema.de

On 11.11.2016, the NMPA published Announcement 147, 2016 concerning the Neutral Red Uptake test as an alternative to animal experiments

Energy efficiency labeling requirements for electric motors in the People's Republic ChinaThe two recent successive announcements with numbers 136 and 137 of the ELAC (Energy Label Administration of China) re-regulate the energy efficiency labeling of electric motors in the People's Republic China. In addition, the update of GB standard 18613-2006 with number GB 18613-2012 was implemented without transition. Currently, the old label is accepted still, but for the next annual report to the ELAC, the current standard must be specified. For this reason, the type of tests must be carried out according to GB 18613-2012 as soon as possible.Currently, the energy efficiency labeling is valid for electric drives for 3-phase asynchronous motors. In the future, synchronous motors with permanent magnets and 3-phase induction motors will be affected also.More information on energy efficiency labeling in the VR China can be obtained from us. Please let us know if you need anything.

China Food and Drug Administration (NMPA) report on registration of medical devices in China.NMPA recently published its Annual Report 2016 on medical device registration. The number of registrations in Class II, III and IVD has increased to 8.653, which is a plus of 14.9 % compared to the previous year. The retracement suffered in 2015 was due to the various regulatory changes dating back to 2014 as well as the increase of application fees in 2015, but the current figures have reached the 2014 level again.A large percentage of applications for the registration of medical devices and IVD comes from abroad. Class II had 3.095 applications from abroad, which is an increase of 2% compared to 2015 and in Class III there were 2.818 applications, an increase of even 15%.The P.R. China continues to promote the import of high-end and high-cost medical devices from abroad. The top five class II and III product groups of foreign origin to be registered in 2016 were:
According to the NMPA report 2016, top of the list of registrations of foreign class II and III products (including IVD) were the USA followed by Germany, places 3, 4 and 5 were held by Japan, United Kingdom and Korea.Further information concerning this topic can be obtained from:Cisema GmbHTel.: +49 89 4161 7389–00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com
And discover how we can support you in getting your products certified for China.